etoposide is one of the most active single agents in small-cell bronchus carcinoma with a remission rate of 37 % ( 10 % cr ) , and is very active in nhl ( 36 % ) , testicular carcinoma ( 37 % ) , amml ( 35 % ) , choriocarcinoma ( 35 % ) , and neuroblastoma ( 29 % ) .
C0015133
etoposide
C0027819
neuroblastoma